Search the Newsreel

Surgery Partners (NASDAQ:SGRY) Downgraded by Zacks Research to Hold

Zacks Research downgraded Surgery Partners (NASDAQ:SGRY) from "Strong Buy" to "Hold," leading to a 6% drop in the stock price despite the company exceeding Q2 earnings and revenue estimates. While the broader analyst consensus remains a "Moderate Buy" with an average target of $19.45, …

Surgery Partners (SGRY) Stock Drops As Idaho Falls Sale Reshapes Debt Story

Surgery Partners (SGRY) stock dropped almost 6% despite a recent quarter showing revenue of US$849 million and adjusted EBITDA margin near 14.7%. The company plans to divest its Idaho Falls asset for US$795 million to reduce debt and simplify its business, though the sale …

Cantor Fitzgerald reiterates Surgery Partners stock rating at Overweight

Cantor Fitzgerald has reiterated its Overweight rating and $18.00 price target for Surgery Partners (NASDAQ:SGRY) stock, citing that the market undervalues the positive impact of the Idaho Falls divestiture on cash conversion. This sale is expected to improve free cash flow conversion by approximately …

Benchmark reiterates Buy rating on Surgery Partners stock at $24

Benchmark has reiterated a Buy rating on Surgery Partners (NASDAQ:SGRY) with a $24 price target, implying a 50% upside from its current stock price. This follows the company's Q2 results and reaffirmed full-year guidance, including details on the planned sale of two Idaho Falls …

RBC Capital Adjusts Price Target on Surgery Partners to $19 From $20, Keeps Outperform Rating

RBC Capital has adjusted its price target for Surgery Partners (SGRY) from $20 to $19, while maintaining an "Outperform" rating on the stock. This adjustment follows several recent announcements from Surgery Partners, including their Q2 2026 earnings report, which showed increased revenue despite a …

Earnings call transcript: Surgery Partners misses Q2 2026 EPS, revenue beats

Surgery Partners (SGRY) reported a wider-than-expected loss for Q2 2026, with adjusted earnings of negative $0.12 per share against an estimated profit of $0.06, despite revenue beating forecasts at $848.9 million. The company announced a significant portfolio optimization with the sale of its Idaho …

SGRY Q2 Deep Dive: Portfolio Optimization and Acuity Mix Lead Operating Shift

SGRY Q2 Deep Dive: Portfolio Optimization and Acuity Mix Lead Operating Shift Healthcare company Surgery Partners (NASDAQ:SGRY) beat Wall Street's revenue expectations in Q2 CY2026, with sales up 2.7% year on year to $848.9 million. The company expects the full year's revenue to be …

Surgery Partners, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:SGRY)

Surgery Partners, Inc. (SGRY) released its Q2 2026 earnings, reporting an EPS of $0.10, which beat estimates by $0.04. The company also reported revenue of $848.90 million, a 2.75% year-over-year increase, exceeding expectations by $18.58 million. This article provides access to the slide deck …

Surgery Partners (NASDAQ: SGRY) posts Q2 2026 loss and plans $795M hospital sale

Surgery Partners (NASDAQ: SGRY) reported a widened net loss of $15.0 million in Q2 2026, up from $2.5 million a year prior, despite a 2.7% increase in revenues to $848.9 million, primarily due to rising operating costs and interest expenses. The company also disclosed …

Surgery Partners Crushes Q2 2026 Profit Estimates by 66.7%

Surgery Partners (NASDAQ:SGRY) Shares Gap Up After Better-Than-Expected Earnings

Surgery Partners shares edge lower despite Q2 revenue beat

Surgeons operating ©Adobe Stock Images Surgery Partners, Inc. (NASDAQ:SGRY) shares slipped 0.71% in pre-market trading on Monday after the healthcare services company reported mixed second-quarter results, with revenue exceeding Wall Street forecasts while profitability remained under pressure. Adjusted earnings per share came in at …

Surgery Partners (SGRY) Q2 Earnings and Revenues Beat Estimates

Is Surgery Partners Inc (SGRY) a Value Trap? Q2 EPS at -$0.15 on $848.9 Million Revenue; GF Score: 57/100

Surgery Partners Inc (SGRY) reported Q2 2026 results with revenue up 2.7% year-over-year to $848.9 million, but a net loss of $15 million, significantly higher than the $2.5 million loss in Q2 2025. Despite revenue growth and reaffirmed 2026 guidance, the company faces challenges …

Surgery Partners (NASDAQ:SGRY) Posts Quarterly Earnings Results, Beats Expectations By $0.04 EPS

Surgery Partners (NASDAQ:SGRY) Beats Q2 CY2026 Sales Expectations

Surgery Partners (NASDAQ:SGRY) Beats Q2 CY2026 Sales Expectations Healthcare company Surgery Partners (NASDAQ:SGRY) reported Q2 CY2026 results beating Wall Street's revenue expectations , with sales up 2.7% year on year to $848.9 million. The company expects the full year's revenue to be around $3.4 …

Surgery Partners: Q2 Earnings Snapshot

Surgery Partners Reports $15M Q2 Net Loss, Revenue Up 2.7%

Surgery Partners (NASDAQ: SGRY) reported a Q2 2026 net loss of $15.0 million, widening from $2.5 million in the prior year, despite a 2.7% increase in revenue to $848.9 million. Adjusted EBITDA decreased to $125.2 million from $129.0 million, and operating cash flow also …

Surgery Partners, Inc. Announces Second Quarter 2026 Results Reaffirms Full Year 2026 Guidance

Surgery Partners, Inc. announced its financial results for the second quarter ended June 30, 2026, reporting a 2.7% increase in revenue to $848.9 million and reaffirming its full-year 2026 revenue guidance of $3.35 billion to $3.45 billion and Adjusted EBITDA of at least $530 …

Surgery Partners GAAP EPS of -$0.12 misses by $0.05, revenue of $848.9M beats by $18.58M

* Surgery Partners press release [https://seekingalpha.com/pr/20612716-surgery-partners-inc-announces-second-quarter-2026-results-reaffirms-full-year-2026-guidance] (SGRY [https://seekingalpha.com/symbol/SGRY]): Q2 GAAP EPS of -$0.12 misses by $0.05. * Revenue of $848.9M (+2.7% Y/Y) beats by $18.58M. * Same-facility revenues increased 5.0% for the second quarter * Same-facility cases increased 0.3% for the second quarter * …

Surgery Partners (SGRY) Q2 Earnings: What To Expect

Surgery Partners (SGRY) is set to announce its Q2 earnings before market hours on Monday. The company beat revenue and EPS expectations last quarter, but analysts expect flat year-on-year revenue growth for the upcoming quarter. Despite some positive sentiment in the outpatient & specialty …

Surgery Partners, Inc. (SGRY) stock price, news, quote and history

This Yahoo Finance page provides comprehensive financial information for Surgery Partners, Inc. (SGRY), including its current stock price, recent news, historical data, and analyst insights. It details the company's business overview, performance against benchmarks like the S&P 500, and key financial metrics. The page …

SURGERY PARTNERS Q2 2026 Earnings Preview: Recent $SGRY Insider Trading, Hedge Fund Activity, and More

SURGERY PARTNERS ($SGRY) is set to release its Q2 2026 earnings on August 10th, with analysts expecting $846.97 million in revenue and $0.06 EPS. Recent insider trading shows 12 sales and no purchases in the last six months, totaling over $1.2 million in sales …

Surgery Partners Inc (SGRY) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Surgery Partners Inc (SGRY), highlighting its current earnings forecast score, analyst ratings, and price targets. It details expected revenue and EPS for upcoming quarters and compares SGRY's ratings to its peers in the Healthcare Providers & Services …

Surgery Partners, Inc. (NASDAQ:SGRY) Given Consensus Rating of "Moderate Buy" by Brokerages

Surgery Partners, Inc. (NASDAQ:SGRY) has received a consensus "Moderate Buy" rating from brokerages, with an average 12-month price target of $21.60. The company recently exceeded earnings expectations, reporting a smaller-than-expected loss and higher revenue. Institutional ownership has also shown a recent increase, indicating growing …

Does Surgery Partners' (SGRY) Reaffirmed 2026 Outlook Clarify Its Execution Strength or Strategic Limits?

Surgery Partners, Inc. (SGRY) has reaffirmed its 2026 revenue outlook of US$3.35 billion to US$3.45 billion, signaling management's confidence in operational execution. While this provides near-term clarity, it does not alleviate concerns regarding the company's leverage, rising interest costs on US$2.2 billion of debt, …

Surgery Partners (SGRY) to Announce Quarterly Earnings on Monday

Is Surgery Partners (SGRY) Fully Valued On Reaffirmed 2026 Guidance?

Strength Seen in Surgery Partners (SGRY): Can Its 5.3% Jump Turn into More Strength?

Surgery Partners SGRY shares rallied 5.3% in the last trading session to close at $16.41. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 7.3% loss over …

SGRY|Surgery Partners Inc|Price:16.400|Chg%:+0.820

This article provides a comprehensive stock analysis of Surgery Partners Inc (SGRY) from TradingKey, highlighting its strong fundamentals, high growth potential, and "fairly valued" status. The company operates 162 surgical facilities and has seen steady revenue and profit growth. Despite recent weak market performance, …

Should Surgery Partners’ Reaffirmed 2026 Revenue Outlook Require Action From Surgery Partners (SGRY) Investors?

Surgery Partners, Inc. reaffirmed its 2026 revenue guidance of US$3.35 billion to US$3.45 billion, signaling management's confidence despite mixed short-term share performance. This outlook supports the near-term catalyst of hitting guidance but does not fully address risks like higher interest costs or slow acquisition …

Surgery Partners Inc (SGRY) Institutional Confidence

The article provides an overview of Surgery Partners Inc (SGRY) institutional confidence score, which stands at 10.00, ranking it 1st in the Healthcare Providers & Services industry. Institutional shareholding has increased by 5.74% quarter-over-quarter, with Bill Nygren | OAKMX being the largest institutional shareholder …

Press Release: Surgery Partners Announces Entry Into Agreement to Sell Ownership Interests in Idaho Falls Facilities to Intermountain Health; Reaffirms Guidance, Excluding Impact of Transaction

Surgery Partners has announced an agreement to sell its ownership interests in two Idaho Falls medical facilities, Idaho Falls Community Hospital and Mountain View Hospital, to Intermountain Health. The transaction, valued at $450 million, is expected to close in Q4 2024 and will allow …